The global adult malignant glioma therapeutics market is expected to witness significant growth during the forecast period. Emerging markets and considerable investments in research and development are the factors responsible for the growth of this market. Growing cases of brain tumor drive the adult malignant glioma therapeutics market. Due to the acceptance of an unhealthy lifestyle, genetic modification, increased age, excessive exposure to radiation and family history with brain cancer also boost up the adult malignant glioma therapeutics market growth. Elderly people are more likely to get cancer sooner in life, typically before the age of 50. To a lesser extent, there is also a higher risk of acquiring other types of cancer, such as prostate cancer, melanoma, and pancreatic cancer. COVID-19 also had a major impact on the market growth.
